title: Elevated serum-soluble ELAM-1 levels in patients with severe plaque-type psoriasis.
authors.affiliation: Universitäts-Hautklinik Hamburg-Eppendorf, Germany.
authors.forename: L
authors.initials: L
authors.lastname: Kowalzick
authors.forename: K
authors.initials: K
authors.lastname: Neuber
authors.forename: M
authors.initials: M
authors.lastname: Weichenthal
authors.forename: I
authors.initials: I
authors.lastname: Köhler
authors.forename: J
authors.initials: J
authors.lastname: Ring
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000875:Anthralin / Q000008:administration & dosage / Q000627:therapeutic use; D015815:Cell Adhesion Molecules / Q000097:blood* / Q000502:physiology; D003131:Combined Modality Therapy; D019040:E-Selectin; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000097:blood* / Q000188:drug therapy / Q000532:radiotherapy
chemical_list: D015815:Cell Adhesion Molecules; D019040:E-Selectin; D018799:Intercellular Adhesion Molecule-1; D000875:Anthralin